Skip to main content
. 2022 Mar 2;13:785570. doi: 10.3389/fgene.2022.785570

TABLE 2.

Genotype frequency among different phenotypes (n = 112).

Variant Zygosity Genotype Phenotype n (%)
SW, n (%) SV, n (%)
I2G Hetero I2G/N 8 (80) 2 (20) 10 (8.9)
Homo I2G/I2G 18 (72) 7 (28) 25 (22.3)
I172N Hetero I172 N/N 1 (100) 0 (0) 1 (0.9)
Homo I172N/I172N 0 (0) 2 (100) 2 (1.8)
F306+T Homo F306 + T/F306 + T 2 (100) 0 (0) 2 (1.8)
LGC (1–3 exon) Hetero LGC/N 1 (100) 0 (0) 1 (0.9)
Homo LGC/LGC 3 (100) 0 (0) 3 (2.7)
1–3 exon Del Homo Del 1–3/Del 1–3 1 (100) 0 (0) 1 (0.9)
1–7 exon Del Homo Del 1–7/Del 1–7 4 (100) 0 (0) 4 (3.6)
-113 SNP, I2G Hetero (-113 SNP, I2G)/N or* -113 SNP/I2G 1 (100) 0 (0) 1 (0.9)
Homo (-113 SNP, I2G)/(-113 SNP, I2G) 2 (100) 0 (0) 2 (1.8)
I2G, 8bp Del Hetero (I2G, 8bp Del)/N or* I2G/8bp Del 2 (100) 0 (0) 2 (1.8)
I2G, I172N Hetero (I2G, I172N)/N or* I2G/I172N 1 (100) 0 (0) 1 (0.9)
I2G, E6 Hetero (I2G, E6)/N or* I2G/E6 2 (100) 0 (0) 2 (1.8)
I2G, F306+T Hetero (I2G, F306 + T)/N or* I2G/F306 + T 1 (100) 0 (0) 1 (0.9)
I172N, F306+T Hetero (I172N, F306 + T)/N or* I172N/F306 + T 0 (0) 1 (100) 1 (0.9)
LGC (1–3 exon), I2G Hetero LGC/I2G 2 (100) 0 (0) 2 (1.8)
LGC (1–4 exon), I2G Hetero LGC/I2G 1 (100) 0 (0) 1 (0.9)
1–3 exon Del, I2G Hetero Del 1–3/I2G 1 (100) 0 (0) 1 (0.9)
LGC (1–3 exon), 1–3 exon Del Hetero LGC/Del 1–3 4 (100) 0 (0) 4 (3.6)
LGC (1–3 exon), 1–7 exon Del Hetero LGC/Del 1–7 0 (0) 1 (100) 1 (0.9)
LGC (1–7 exon), 1–7 exon Del Hetero LGC/Del 1–7 1 (100) 0 (0) 1 (0.9)
LGC (1–4 exon), 30-KB Del (CH-7) Hetero LGC/Del 1 (100) 0 (0) 1 (0.9)
30-KB Del (CH-1) Homo Del/Del 6 (100) 0 (0) 6 (5.4)
Large gene Del (CAH-X CH-1) Homo Dela/Dela 3 (100) 0 (0) 3 (2.7)
No identified variant Homo N/N 22 (66.7) 11 (33.3) 33 (29.5)
Total 88 24 112

LGC, large gene conversion; Del, deletion; N, no identified variant; Homo, homozygous; Hetero, heterozygous; CH-1, chimeric gene produced by 30-KB, Del extending from exon 4 of the CYP21A1P pseudogene to exon 3 of the active CYP21A2 gene; CH-7, chimeric gene produced by 30-KB, Del extending from exon 7 of the CYP21A1P pseudogene to exon 6 of the active CYP21A2 gene; Dela, large gene deletion from the CYP21A2 gene extending to exon 35 of the TNXB gene.

†E6: exon 6 cluster variants (V237E and M239K), SW: salt wasting, SV: simple virilizing.

*Compound heterozygous variants may be in cis or trans configuration and needs further investigations for both parents.